Dose proportionality study of loperamide following oral administration of loperamide oxide. 1992

F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
Wolfson Unit of Clinical Pharamcology, The University, Newcastle upon Tyne, UK.

The pharmacokinetics of loperamide, after oral administration of increasing doses (1 to 16 mg) of loperamide oxide, has been investigated in 10 healthy male volunteers, using a randomised cross-over design. Comparison of the maximum plasma loperamide concentration and AUC demonstrated that the bioavailability of loperamide was proportional to the dose of loperamide oxide administered.

UI MeSH Term Description Entries
D008139 Loperamide One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. Imodium,Loperamide Hydrochloride,Loperamide Monohydrochloride,R-18553,Hydrochloride, Loperamide,Monohydrochloride, Loperamide,R 18553,R18553
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
June 2019, Xenobiotica; the fate of foreign compounds in biological systems,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
February 1996, British journal of clinical pharmacology,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
September 1984, The Journal of clinical psychiatry,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
December 1992, Biopharmaceutics & drug disposition,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
November 1993, Calcified tissue international,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
August 1994, Journal of clinical pharmacology,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
July 1984, Journal of clinical pharmacology,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
January 2021, Toxicology and applied pharmacology,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
August 1989, Research communications in chemical pathology and pharmacology,
F Kamali, and L Adriaens, and M L Huang, and R Woestenborghs, and M Emanuel, and M D Rawlins
February 1998, Anesthesiology,
Copied contents to your clipboard!